(Approval lapsed) ESTRAMON estradiol 25 microgram/24 hour transdermal patch (Germany)
Short-term treatment of signs and symptoms of estrogen deficiency due to the menopause, whether natural or surgically induced. In women with intact uteri, estrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.
Please note: CONTAINS SOYBEAN OIL. The section 19A approved medicine is contraindicated in patients with known hypersensitivity to the active ingredient, soy, peanut or any of the other ingredients listed. Prior to dispensing and administering, healthcare professionals should determine if this product is suitable for the patient.